REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) › Shareholders' EquityREVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$5.96M2019: -$6.81M2020: $5.47M2021: $28.69M2022: $8.39M2023: $5.72M2024: $812.6K2025: $8.65M$8.65M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$8.65M+964.2%2024$812.6K-85.8%2023$5.72M-31.9%2022$8.39M-70.7%2021$28.69M+424.8%2020$5.47M+180.2%2019-$6.81M-14.2%2018-$5.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share